Filing Flows › Rockwell Medical (RMTI) › Capital expenditures
Rockwell Medical (RMTI) capital expenditures by quarter
Rockwell Medical's capital expenditures were $617K in Q2 2026 (second quarter 2026), +617% from Q4 2025. Over the last 4 quarters it ranged from $86K (Q4 2025) to $617K (Q2 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $617K | +617% | +276% |
| Q4 2025 | $86K | -48% | -78% |
| Q2 2025 | $164K | -58% | — |
| Q4 2024 | $395K | — | — |
Q2 2026 at a glance
Rockwell Medical, Q2 2026: revenue $17.8M (+11% year over year), operating margin -6.0%, net loss $1.2M, operating cash flow $2.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Rockwell Medical's capital expenditures?
Rockwell Medical's capital expenditures were $617K in Q2 2026 (second quarter 2026), +617% from Q4 2025.
How has Rockwell Medical's capital expenditures changed?
Over the last 4 quarters it ranged from $86K (Q4 2025) to $617K (Q2 2026).